Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this ...

Analysts believe each of the stocks below has the potential to at least double in price, although the three firms also carry ...

Shares of Novavax Inc. NVAX rallied 2.53% to $7.29 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP ri ...

Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after BioMarin BMRN agreed to ...

This was the stock's second consecutive day of losses.

The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The approval marks a significant milestone for Novavax Inc. (NASDAQ:NVAX), aligning with the changing regulatory landscape ...

Shares of vaccine makers saw an uptick in the latest trading session, with Moderna Inc (BMV:MRNA). (NASDAQ:MRNA) leading the ...

The member states of the World Health Organization (WHO) on Tuesday adopted a landmark agreement to promote the timely and ...

U.S. stocks settled mostly higher on Monday, with the Dow Jones index gaining more than 100 points during the session. Major ...

At 2:05 p.m., the Dow Jones Industrial Average rose 101.99 points, or 0.23%, to 42,756.73, the S&P 500 lost 1.25 points, or 0.02%, to 5,957.07 and the Nasdaq Composite lost 21.44 points, or 0.11%, to ...